gadolinium dtpa has been researched along with End Stage Liver Disease in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (80.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, J; Ko, JS; Park, S; Woo, JY | 1 |
| Cai, S; Lin, N; Lin, X; Ma, W; Wang, X; Wang, Y; Yang, Y; Zhao, X | 1 |
| Denecke, T; Elkilany, A; Fischer, A; Geisel, D; Müller, T | 1 |
| Cho, HC; Choi, HC; Choi, HY; Han, F; Kim, JE; Nickel, MD; Park, MJ; Shin, HS; Won, JH; Yang, W | 1 |
| Asayama, Y; Fujita, N; Honda, H; Ikegami, T; Ishigami, K; Morita, K; Nishie, A; Okamoto, D; Shirabe, K; Takayama, Y; Ushijima, Y; Yoshizumi, T | 1 |
| Bernasconi, D; Famularo, S; Giani, A; Ippolito, D; Orsini, EB; Pecorelli, A; Romano, F; Sironi, S; Talei Franzesi, C | 1 |
| Ahn, SH; Jung, SE; Kim, JK; Kim, KS; Kim, MJ; Kim, YC; Park, YN | 1 |
| Chen, J; Gu, HY; Hu, J; Hua, J; Wu, LM; Xu, JR; Zhang, W; Zhu, J | 1 |
| Choi, D; Kim, MY; Kim, YK; Lee, WJ; Park, HJ; Park, MJ | 1 |
| Barreiros, A; Fellner, C; Haimerl, M; Loss, M; Schlabeck, M; Schreyer, AG; Stroszczynski, C; Verloh, N; Wiggermann, P; Zeman, F | 1 |
| Hernando, D; Reeder, SB; Vigen, KK; Wells, SA | 1 |
| Choi, D; Kang, TW; Kim, HS; Kim, SH; Park, CK; Song, KD | 1 |
| Higaki, A; Higashi, H; Ito, K; Kanki, A; Tamada, T; Tanimoto, D; Yoshida, K | 1 |
| Chernyak, V; Kim, J; Mazzoriol, F; Ricci, Z; Rozenblit, AM | 1 |
| Araki, T; Ehman, RL; Ichikawa, T; Motosugi, U; Muhi, A; Sano, K; Sou, H | 1 |
| Higaki, A; Higashi, H; Ito, K; Kanki, A; Sato, T; Sone, T; Tamada, T; Tanimoto, D | 1 |
| Adsay, V; Farris, AB; Hanish, S; Kalb, B; Kitajima, H; Lauenstein, T; Lurie, C; Martin, DR; Martinez, E; Moreira, R; Salman, K; Sharma, P; Spivey, J | 1 |
| Akata, S; Araki, Y; Ledsam, J; Otaka, J; Saito, K; Sourbron, S; Tokuuye, K | 1 |
| Higaki, A; Higashi, H; Ito, K; Kanki, A; Sato, T; Tamada, T; Taniomoto, D; Yamamoto, A; Yasokawa, K | 1 |
| Hori, M; Hyodo, T; Imai, Y; Kagawa, Y; Kogita, S; Kudo, M; Kumano, S; Mochizuki, T; Murakami, T; Okada, M | 1 |
1 trial(s) available for gadolinium dtpa and End Stage Liver Disease
| Article | Year |
|---|---|
Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity | 2012 |
19 other study(ies) available for gadolinium dtpa and End Stage Liver Disease
| Article | Year |
|---|---|
Prediction of insufficient hepatic enhancement during the Hepatobiliary phase of Gd-EOB DTPA-enhanced MRI using machine learning classifier and feature selection algorithms.
Topics: Algorithms; Contrast Media; End Stage Liver Disease; Gadolinium DTPA; Humans; Liver; Machine Learning; Magnetic Resonance Imaging; Retrospective Studies; Severity of Illness Index | 2022 |
The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease.
Topics: Contrast Media; End Stage Liver Disease; Gadolinium DTPA; Humans; Liver Cirrhosis; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Portal Vein; Retrospective Studies; Severity of Illness Index | 2023 |
Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression.
Topics: Adult; Cholangitis, Sclerosing; Contrast Media; Disease Progression; End Stage Liver Disease; Gadolinium DTPA; Humans; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Severity of Illness Index | 2021 |
T2 mapping in gadoxetic acid-enhanced MRI: utility for predicting decompensation and death in cirrhosis.
Topics: End Stage Liver Disease; Gadolinium DTPA; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Retrospective Studies; Severity of Illness Index | 2021 |
Does apparent diffusion coefficient predict the degree of liver regeneration of donor and recipient after living donor liver transplantation?
Topics: Adult; Contrast Media; Diffusion Magnetic Resonance Imaging; End Stage Liver Disease; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Liver; Liver Regeneration; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed; Transplant Donor Site; Transplants; Young Adult | 2017 |
Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
Topics: Aged; Contrast Media; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies | 2019 |
Relationship between severity of liver dysfunction and the relative ratio of liver to aortic enhancement (RE) on MRI using hepatocyte-specific contrast.
Topics: Aged; Aorta; Contrast Media; End Stage Liver Disease; Female; Gadolinium DTPA; Hepatocytes; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Regression Analysis; Retrospective Studies; Risk; Severity of Illness Index | 2014 |
Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease?
Topics: Carcinoma, Hepatocellular; Contrast Media; End Stage Liver Disease; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Sensitivity and Specificity | 2013 |
Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging?
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Observer Variation; Reference Standards; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2014 |
Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
Topics: Adult; Aged; Contrast Media; End Stage Liver Disease; Evaluation Studies as Topic; Female; Gadolinium DTPA; Hepatocytes; Humans; Liver Diseases; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Severity of Illness Index | 2014 |
Effect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎).
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Contrast Media; End Stage Liver Disease; Female; Gadolinium; Gadolinium DTPA; Hepatocytes; Humans; Image Processing, Computer-Assisted; Linear Models; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed; Ultrasonography; Water; Young Adult | 2015 |
Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; Contrast Media; Diffusion Magnetic Resonance Imaging; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Sensitivity and Specificity | 2015 |
Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Time Factors | 2011 |
Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography.
Topics: Aged; Aged, 80 and over; Contrast Media; Dose-Response Relationship, Drug; Elastic Modulus; Elasticity Imaging Techniques; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Liver MRI and histological correlates in chronic liver disease on multiphase gadolinium-enhanced 3D gradient echo imaging.
Topics: Adult; Aged; Contrast Media; Echo-Planar Imaging; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Imaging, Three-Dimensional; Liver; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2012 |
Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol.
Topics: Aged; Algorithms; Computer Simulation; Contrast Media; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Models, Biological; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Simple Method for evaluating the degree of liver parenchymal enhancement in the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; End Stage Liver Disease; Female; Gadolinium DTPA; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Proportional Hazards Models; Retrospective Studies; Risk Factors; ROC Curve; Sensitivity and Specificity | 2013 |